Skip to main content
Veterinary Medicines

TABERNIL ANTIASMATICO

Authorised
  • Diphenhydramine hydrochloride
  • Ephedrine hydrochloride
  • Theophylline
  • Dexamethasone sodium phosphate

Product identification

Medicine name:
TABERNIL ANTIASMATICO
Active substance:
  • Diphenhydramine hydrochloride
  • Ephedrine hydrochloride
  • Theophylline
  • Dexamethasone sodium phosphate
Target species:
  • Ornamental bird
Route of administration:
  • In drinking water use

Product details

Active substance and strength:
  • Diphenhydramine hydrochloride
    0.80
    milligram(s)
    /
    1.00
    millilitre(s)
  • Ephedrine hydrochloride
    2.00
    milligram(s)
    /
    1.00
    millilitre(s)
  • Theophylline
    4.00
    milligram(s)
    /
    1.00
    millilitre(s)
  • Dexamethasone sodium phosphate
    0.04
    milligram(s)
    /
    1.00
    millilitre(s)
Pharmaceutical form:
  • Solution for use in drinking water
Withdrawal period by route of administration:
  • In drinking water use
    • Ornamental bird
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QR03CK
Authorisation status:
  • Valid
Authorised in:
  • Spain
Available in:
  • Spain
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Marketing authorisation holder:
  • Divasa Farmavic S.A.
Marketing authorisation date:
Manufacturing sites for batch release:
  • Divasa Farmavic S.A.
Responsible authority:
  • Spanish Agency For Medicines And Health Products
Authorisation number:
  • 2066 ESP
Date of authorisation status change:

Documents

Summary of Product Characteristics

This document does not exist in this language (English). You can find it in another language below.
Spanish (PDF)
Published on: 9/11/2022

Package Leaflet

This document does not exist in this language (English). You can find it in another language below.
Spanish (PDF)
Published on: 9/11/2022

Labelling

This document does not exist in this language (English). You can find it in another language below.
Spanish (PDF)
Published on: 9/11/2022
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."